Chinese vaccine makers jump on news of key success in cancer treatment

Genscript Biotech

20/08/2026 10:05

Updates
** HK-listed shares of Chinese vaccine makers rally, while China's CSI Vaccine and Biotech Index .CSI931992 jumps 9.2% after Moderna MRNA.O and Merck MRK.N on Wednesday announced a major success in a new field of cancer treatment
** CanSino Biologics's HK shares 6185.HK soar as much as 71.4% to HK$40, their highest point since January 2; Shanghai shares 688185.SS jump 20% to their highest level since May 25
** Genscript Biotech Corp 1548.HK jumps nearly 20% to HK$35.22, highest level since December 2021
** Sino Biopharmaceutical 1177.HK surges as much as 21.2% to HK$5.805, the highest since May 12
** Akeso Inc 9926.HK, Innovent Biologics 1801.HK, WuXi Biologics 2269.HK up between 3.1% and 5.7% 
** Hong Kong's Hang Seng Innovative Drug Index .HSIDI surges 4.7%, Hang Seng Biotech Index HSBIO up 4.5%
** However, Jiangsu Hengrui Pharmaceuticals' HK shares 1276.HK drop 9.6%, while Shanghai shares 600276.SS fall 6% after missing quarterly profit views

(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))